Skip to main content

Table 2 The cell cycle distribution of HepG2 cells in the low expression group and control group

From: CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

Group

G1 (%)

S (%)

G2/M (%)

Control group

57.44 ± 1.25

29.92 ± 0.22

11.73 ± 1.97

Low CDCA5 expression group

45.81 ± 3.37

27.37 ± 2.78

27.53 ± 0.58

P value

0.005

0.189

< 0.001